STIM
Neuronetics, Inc.NASDAQHealthcare$1.52+2.01%ClosedMarket Cap: $105.3M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
5.41
P/S
0.82
EV/EBITDA
-6.37
DCF Value
$-56.23
FCF Yield
-17.4%
Div Yield
0.0%
Margins & Returns
Gross Margin
48.5%
Operating Margin
-21.1%
Net Margin
-26.1%
ROE
-138.9%
ROA
-27.6%
ROIC
-27.0%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $41.8M | 52.0% | $-5.0M | $-7.2M | $-0.10 | — |
| FY 2025 | $149.2M | 48.5% | $-31.4M | $-39.0M | $-0.59 | — |
| Q3 2025 | $37.3M | 45.9% | $-7.3M | $-9.0M | $-0.13 | — |
| Q2 2025 | $38.1M | 46.6% | $-8.1M | $-10.1M | $-0.15 | — |
| Q1 2025 | $32.0M | 49.2% | $-11.0M | $-12.7M | $-0.21 | — |
| Q4 2024 | $22.5M | 66.2% | $-11.5M | $-12.7M | $-0.33 | — |
| FY 2024 | $74.9M | 72.3% | $-34.6M | $-43.7M | $-1.38 | — |
| Q3 2024 | $18.5M | 75.6% | $-7.7M | $-13.3M | $-0.44 | — |
| Q2 2024 | $16.4M | 74.0% | $-8.5M | $-9.8M | $-0.33 | — |
| Q1 2024 | $17.4M | 75.1% | $-6.9M | $-7.9M | $-0.27 | — |
| Q4 2023 | $20.3M | 77.6% | $-4.4M | $-5.4M | $-0.19 | — |
| FY 2023 | $71.3M | 72.5% | $-30.6M | $-30.2M | $-1.05 | — |